摘要:
Compounds according to Formula (I) or a pharmaceutically acceptable salt thereof are GABA-A Alpha 5 ligands useful for enhancing cognition: where A is C1-6alkyl, C2-6alkenyl, C2-6alkynyl, C3-6cycloalkyl, arylC1-6alkyl, or aryl wherein the aryl group is optionally substituted by halogen, C1-6alkyl, CF3, CN, NO2 or NH2, NR1R10, S(O)pR1, heteroarylC1-6alkyl or heteroaryl where heteroaryl is a 5- or 6-membered heteroaromatic ring as defined for B; and B is phenyl or a 5-membered ring having one or two unsaturations containing 1, 2, 3, or 4 heteroatoms chosen from O, N and S provided that not more than one heteroatom is other than N, a 6-membered heteroaromatic ring containing 1, 2, 3 or 4 nitrogen atoms, each of which rings is optionally substituted by one or more substituents.
摘要翻译:根据式(I)的化合物或其药学上可接受的盐是可用于增强认知的GABA-Aα5配体:其中A是C 1-6烷基,C 2-6烯基,C 2-6炔基,C 3-6环烷基,芳基C 1-6烷基或芳基 其中芳基任选被卤素,C 1-6烷基,CF 3,CN,NO 2或NH 2,NR 1 R 10,S(O)p R 1,杂芳基C 1-6烷基或杂芳基取代,其中杂芳基是5-或6-元杂芳环, B; 并且B是苯基或具有1或2个不饱和基团的5元环,其含有1,2,3或4个选自O,N和S的杂原子,条件是不超过一个杂原子不是N,6元杂芳环 含有1,2,3或4个氮原子,其中每个环任选被一个或多个取代基取代。
摘要:
Substituted heterocycles of the general structural formula: are tachykinin receptor antagonists useful in the treatment of inflammatory diseases, pain or migraine, asthma and emesis, and calcium channel blockers useful in the treatment of cardiovascular conditions such as angina, hypertension or ischemia.
摘要:
Substituted heterocycles of the general structural formula: ##STR1## are tachykinin receptor antagonists useful in the treatment of inflammatory diseases, pain or migraine, asthma and emesis, and calcium channel blockers useful in the treatment of cardiovascular conditions such as angina, hypertension or ischemia.